Lunai Bioworks Inc.
LNAI
$1.25
-$0.01-0.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 102.22% | -67,083.19% | 102.61% | 83.60% | -181.04% |
| Total Depreciation and Amortization | 27.30% | 1.88% | -0.31% | -0.93% | 4.18% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -64.98% | -72.38% |
| Total Other Non-Cash Items | -104.24% | 4,177.05% | -182.21% | -90.83% | 322.11% |
| Change in Net Operating Assets | -35.80% | 18.00% | 35.34% | -51.78% | -45.42% |
| Cash from Operations | 25.51% | -21.75% | 41.89% | -26.95% | 16.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.52% | 165.86% | -- | -- | -- |
| Cash from Investing | -43.52% | 165.86% | -- | -- | -- |
| Total Debt Issued | -53.19% | 303.08% | -65.97% | 1,502.93% | -94.17% |
| Total Debt Repaid | 0.00% | 0.00% | -33.14% | 8.89% | 0.00% |
| Issuance of Common Stock | -- | -- | 971.43% | -86.64% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 653.03% | -95.02% | 38.34% | 27.69% | -17.74% |
| Foreign Exchange rate Adjustments | 95.80% | -663.68% | -135.39% | 567.97% | 86.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 164.09% | -235.85% | 570.18% | 91,100.00% | 100.11% |